Novel substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase

• 收藏
• 分享

专利权人:

Merck Sharp & Dohme Corp.;Iomet Pharma Ltd.

发明人:

Cowley, Phillip, M.,McGowan, Meredeth Ann,Brown, Thomas J.,Han, Yongxin,Liu, Kun,Pu, Qinglin,Wise, Alan,Zhang, Hongjun,Zhou, Hua

申请号：

AU2017257377

公开号：

AU2017257377A1

申请日:

2017.04.24

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Disclosed herein are substituted imidazopyridine compounds of formula (I) which are inhibitors of indoleamine 2,3-dioxygenase (IDO) and/or tryptophan-2,3-dioxygenase (TDO) enzymes: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO- and/or TDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO- and/or TDO-associated disease or disorder.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/